Published in Br J Pharmacol on December 01, 1992
Diabetes-induced vascular dysfunction involves arginase I. Am J Physiol Heart Circ Physiol (2011) 1.03
Effects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries. Cardiovasc Diabetol (2009) 0.93
Sexual dimorphism in rat aortic endothelial function of streptozotocin-induced diabetes: possible involvement of superoxide and nitric oxide production. Eur J Pharmacol (2013) 0.78
Caffeic acid phenethyl amide improves glucose homeostasis and attenuates the progression of vascular dysfunction in Streptozotocin-induced diabetic rats. Cardiovasc Diabetol (2013) 0.78
The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation. Br J Pharmacol (2004) 0.77
The effect of insulin treatment and of islet transplantation on the resistance artery function in the STZ-induced diabetic rat. Br J Pharmacol (1996) 0.77
Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells. J Clin Invest (1996) 0.77
Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease. Front Physiol (2015) 0.75
The effect of long-term streptozotocin-induced diabetes on contractile and relaxation responses of coronary arteries: selective attenuation of CGRP-induced relaxations. Br J Pharmacol (2000) 0.75
Effects of a PPAR-gamma receptor agonist and an angiotensin receptor antagonist on aortic contractile responses to alpha receptor agonists in diabetic and/or hypertensive rats. Cardiovasc J Afr (2016) 0.75
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (1976) 13.19
Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev (1974) 7.76
The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol (1984) 6.74
The nature of endothelium-derived vascular relaxant factor. Nature (1984) 5.53
Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest (1989) 5.01
Regulatory functions of the vascular endothelium. N Engl J Med (1990) 4.72
Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature (1983) 4.64
Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. J Clin Invest (1978) 4.35
Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev (1970) 3.10
Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther (1986) 2.80
Log-normal distribution of equiefective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther (1972) 1.99
Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol (1986) 1.87
Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol (1989) 1.63
Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells. Br J Pharmacol (1984) 1.61
Endothelium-dependent relaxation in aorta of BB rat. Diabetes (1987) 1.44
Mediators produced by the endothelial cell. Hypertension (1988) 1.38
Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br J Pharmacol (1988) 1.33
Vascular reactivity in diabetes mellitus: role of the endothelial cell. Br J Pharmacol (1983) 1.32
Enhancement of alpha-1 and alpha-2 adrenergic agonist-induced vasoconstriction by removal of endothelium in rat aorta. J Pharmacol Exp Ther (1985) 1.29
A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit. Br J Pharmacol (1987) 1.25
Vascular prostacyclin may be reduced in diabetes in man. Lancet (1979) 1.25
The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels. Can J Physiol Pharmacol (1985) 1.20
Diabetes and hypertensive vascular disease. Mechanisms and treatment. Am J Cardiol (1973) 1.15
Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat. Am J Physiol (1982) 1.13
The modulatory role of vascular endothelium in the interaction of agonists and antagonists with alpha-adrenoceptors in the rat aorta. Br J Pharmacol (1988) 1.12
Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the alpha-adrenoceptor agonist B-HT 920 in rat isolated aorta. Br J Pharmacol (1984) 1.11
Decreased vascular prostacyclin in experimental diabetes. Life Sci (1978) 1.10
Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci (1987) 1.07
Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur J Pharmacol (1988) 1.07
Nifedipine and alpha adrenoceptors in rat aorta. II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor-mediated contraction in diabetes. J Pharmacol Exp Ther (1984) 1.01
Enhanced vascular alpha-adrenergic neuroeffector system in diabetes: importance of calcium. Am J Physiol (1988) 1.01
Vascular responses to agonists in rat mesenteric artery from diabetic rats. Can J Physiol Pharmacol (1987) 0.96
Role of efficacy in the assessment of the actions of alpha-adrenoceptor agonists in rat aorta with endothelium. J Pharm Pharmacol (1986) 0.95
Vascular responsiveness and eicosanoid production in diabetic rats. Diabetologia (1983) 0.94
Injury of arterial endothelial cells in diabetic, sucrose-fed and aged rats. Atherosclerosis (1984) 0.89
Differential contractile responsiveness of femoral arteries from healthy and diabetic dogs: role of endothelium. Arch Int Pharmacodyn Ther (1987) 0.89
Impact of insulin or tolbutamide treatment on 14C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats. Diabetes (1983) 0.87
Differences in vascular responses to vasoactive agents of basilar artery and aorta from rabbits with alloxan-induced diabetes. Can J Physiol Pharmacol (1990) 0.87
Supersensitivity of isolated mesenteric arteries to noradrenaline in the long-term experimental diabetic rat. J Auton Pharmacol (1981) 0.86
Vascular disease in diabetes: pathophysiological mechanisms and therapy. Arch Intern Med (1979) 0.86
Aortic endothelium of alloxan diabetic rabbits: a quantitative study using scanning electron microscopy. Diabetologia (1982) 0.83
Altered responsiveness of diabetic dog renal arteries to acetylcholine and phenylephrine: role of endothelium. Pharmacology (1989) 0.83
Augmented thromboxane generation by mesenteric arteries from pancreatectomized diabetic dogs is coincident with the vascular tone enhancement evoked by Na arachidonate and prostacyclin. Eur J Pharmacol (1984) 0.76
Heart rate and blood pressure response to methacholine in long term streptozotocin diabetic rats. Proc West Pharmacol Soc (1988) 0.76
Isoflurane: an anesthetic for the eighties? Anesth Analg (1981) 1.42
Minimum alveolar concentrations (MAC) of isoflurande with and without nitrous oxide in patients of various ages. Anesthesiology (1975) 1.21
Hypotensive anesthesia for total hip arthroplasty: a study of blood loss and organ function (brain, heart, liver, and kidney). Anesthesiology (1978) 1.15
Relationship of 133Xe cerebral blood flow to middle cerebral arterial flow velocity in men at rest. J Cereb Blood Flow Metab (1996) 1.10
Propofol produces endothelium-independent vasodilation and may act as a Ca2+ channel blocker. Anesth Analg (1993) 1.08
Comparison of the anesthetic requirement for tolerance of laryngeal mask airway and endotracheal tube. Anesth Analg (1992) 1.06
Controlled substance dispensing and accountability in United States anesthesiology residency programs. Anesthesiology (1992) 1.05
Comparison of the arrhythmic doses of epinephrine during Forane, halothane, and fluroxene anesthesia in dogs. Anesthesiology (1971) 1.04
The cardiovascular effects of a new inhalation anesthetic, Forane, in human volunteers at constant arterial carbon dioxide tension. Anesthesiology (1971) 1.01
Comparative toxicities of halothane, isoflurane, and diethyl ether at subanesthetic concentrations in laboratory animals. Anesthesiology (1975) 0.97
A test of the carcinogenicity of enflurane, isoflurane, halothane, methoxyflurane, and nitrous oxide in mice. Anesth Analg (1979) 0.96
The dependence of pancuronium- and d-tubocurarine-induced neuromuscular blockades on alveolar concentrations of halothane and forane. Anesthesiology (1972) 0.96
The ventilatory effects of Forane, a new inhaled anesthetic. Anesthesiology (1971) 0.95
The electroencephalogram in man anesthetized with forane. Anesthesiology (1971) 0.94
Multiform ventricular tachycardia due to the interaction of aminophylline and halothane. Anesth Analg (1979) 0.94
Ethical issues in anesthesia: management of the do-not-resuscitate patient. Anesth Analg (1991) 0.92
Comparative neuromuscular effects of Forane and halothane alone and in combination with d-tubocurarine in man. Anesthesiology (1971) 0.89
Psychological eff-cts of halothane and isoflurane anesthesia. Anesthesiology (1975) 0.88
The toxicity of fluroxene in animals and man. Anesthesiology (1973) 0.88
Adrenal function during long-term anesthesia in man. Proc Soc Exp Biol Med (1970) 0.87
Forane uptake, excretion, and blood solubility in man. Anesthesiology (1971) 0.86
Midazolam produces vasodilation by mixed endothelium-dependent and -independent mechanisms. Anesth Analg (1994) 0.86
Sister chromatid exchanges induced by inhaled anesthetics. Anesthesiology (1979) 0.84
The cardiovascular effects of halothane in man during spontaneous ventilation. Anesthesiology (1972) 0.83
Comparative toxicities of enflurane, fluroxene and nitrous oxide at subanaesthetic concentrations in laboratory animals. Can Anaesth Soc J (1977) 0.83
Clinical signs of anesthesia. Anesthesiology (1972) 0.83
Comparative neuromuscular effects of pancuronium, gallamine, and succinylcholine during forane and halothane anesthesia in man. Anesthesiology (1971) 0.82
Anesthetic potencies of sulfur hexafluoride, carbon tetrafluoride, chloroform and Ethrane in dogs: correlation with the hydrate and lipid theories of anesthetic action. Anesthesiology (1969) 0.82
The cardiovascular effects of compound 469 (Forane) during spontaneous ventilation and CO2 challenge in man. Anesthesiology (1971) 0.82
Rigidity and hypercarbia associated with high dose fentanyl induction of anesthesia. Anesth Analg (1981) 0.81
Electroencephalographic seizure activity in dogs during anaesthesia. Br J Anaesth (1971) 0.81
The effect of renal failure and hyperkalemia on the duration of pancuronium neuromuscular blockade in man. Anesth Analg (1973) 0.80
The cardiovascular and respiratory effects of isoflurane-nitrous oxide anaesthesia. Can Anaesth Soc J (1974) 0.80
Pancuronium-induced tachycardia in relation to alveolar halothane, dose of pancuronium, and prior atropine. Anesthesiology (1975) 0.79
Comparative evaluation of new inhalation anesthetics. Anesthesiology (1971) 0.78
Clinically relevant concentrations of bupivacaine inhibit rat aortic baroreceptors. Anesth Analg (1994) 0.78
Comparative toxicity of isoflurane, halothane, fluroxene and diethyl ether in human volunteers. Can Anaesth Soc J (1973) 0.77
Surgical stimulation antagonizes the respiratory depression produced by forane. Anesthesiology (1972) 0.77
Fluroxene toxicity in dogs: possible mechanisms. Anesth Analg (1975) 0.77
Heart rate and blood pressure response to methacholine in long term streptozotocin diabetic rats. Proc West Pharmacol Soc (1988) 0.76
New halogenated anesthetics: enflurane and isoflurane. Calif Med (1972) 0.76
[Enhanced myocardial depression from bupivacaine in diabetic rats]. Masui (1991) 0.76
'Do-not-resuscitate' orders in operating rooms. West J Med (1992) 0.75
The effects of ether, halothane, and Forane on apneic thresholds in man. Anesthesiology (1971) 0.75
Antagonism of succinylcholine paralysis in a patient with atypical pseudocholinesterase. Anesthesiology (1972) 0.75
Enflurane and methoxyflurane metabolism at anesthetic and at subanesthetic concentrations. Anesth Analg (1979) 0.75
Malpositioning of endotracheal catheters. JAMA (1966) 0.75
Correlative study of behavior and synaptic events during halothane anesthesia in the lamprey. Anesth Analg (1993) 0.75
The dependence of a d-tubocurarine-induced hypotension on alveolar concentration of halothane, dose of d-tubocurarine, and nitrous oxide. Anesthesiology (1974) 0.75
Recovery from general anesthesia. Int Anesthesiol Clin (1991) 0.75
Influence of organic modifier concentration on plate number in micellar electrokinetic chromatography. 1. 2-propanol. Anal Chem (1998) 0.75
A source of nitrogen in the breathing circuit during closed system anesthesia. Anesthesiology (1996) 0.75
The cardiovascular effects of nitrous oxide-halothane anesthesia in man. Anesthesiology (1971) 0.75
Surgical satellite pharmacies in institutions with anesthesiology training programs for physicians. Am J Hosp Pharm (1992) 0.75
Modification of electroconvulsive therapy induced hypertension with nitroglycerin ointment. Anesthesiology (1985) 0.75
Enflurane metabolism in rats and man. J Pharmacol Exp Ther (1977) 0.75
Failure to detect toxicity with the concomitant use of cyclophosphamide and halothane in humans. Anesthesiology (1986) 0.75
Lung function studies after the intralymphatic injection of emulsions of ethiodol in dogs. Lymphology (1968) 0.75
Species, strain, sex and individual differences in enflurane metabolism. Br J Anaesth (1975) 0.75
Human tolerance and physiological responses to exercise while breathing oxygen at 2.0 ATA. Aviat Space Environ Med (1995) 0.75
Anesthetic management. Anesth Analg (1976) 0.75
Circulatory studies during spinal anesthesia: central and peripheral venous oxygen saturation before and after administration of vasopressors. Anesth Analg (1969) 0.75